Key facts
- This page summarizes Christopher P. Lowe's Form 4 filing for Cortexyme, Inc. (QNCX).
- 9 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Aug 2021, 17:25.
Christopher P. Lowe - 16 Aug 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)
- Reporting relationship
- COO & Chief Financial Officer
- Issuer ticker
- QNCX
- Reported as of
- 16 Aug 2021
- Net transaction value
- -$1,980,819
- SEC form
- 4
- Accepted by SEC
- 18 Aug 2021, 17:25:23 UTC
- Prior SEC filing
- 30 Jun 2021
- Next SEC filing
- 07 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher P. Lowe filed Form 4 for Cortexyme, Inc. (QNCX) on 18 Aug 2021.
Change
- Previous filing in this sequence was filed on 30 Jun 2021.
- Current net transaction value: -$1,980,819.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QNCX
transaction
Common Stock
Options Exercise
- Transaction value
- $49,060
- Shares
- +22,000
- Change %
- +73%
- Price
- $2.23
- Shares after
- 52,000
- Date
- 16 Aug 2021
- Ownership
- Direct
QNCX
transaction
Common Stock
Sale
- Transaction value
- $862,958
- Shares
- -9,158
- Change %
- -18%
- Price
- $94.23
- Shares after
- 42,842
- Date
- 16 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F2
QNCX
transaction
Common Stock
Sale
- Transaction value
- $696,972
- Shares
- -7,335
- Change %
- -17%
- Price
- $95.02
- Shares after
- 35,507
- Date
- 16 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F3
QNCX
transaction
Common Stock
Sale
- Transaction value
- $224,426
- Shares
- -2,330
- Change %
- -6.6%
- Price
- $96.32
- Shares after
- 33,177
- Date
- 16 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F4
QNCX
transaction
Common Stock
Sale
- Transaction value
- $107,008
- Shares
- -1,100
- Change %
- -3.3%
- Price
- $97.28
- Shares after
- 32,077
- Date
- 16 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F5
QNCX
transaction
Common Stock
Sale
- Transaction value
- $205,415
- Shares
- -2,077
- Change %
- -6.5%
- Price
- $98.90*
- Shares after
- 30,000
- Date
- 16 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
QNCX
transaction
Common Stock
Options Exercise
- Transaction value
- $66,900
- Shares
- +30,000
- Change %
- +100%
- Price
- $2.23
- Shares after
- 60,000
- Date
- 17 Aug 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QNCX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -22,000
- Change %
- -12%
- Price
- $0.000000
- Shares after
- 163,294
- Date
- 16 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,000
- Exercise price
- $2.23
- Footnotes
- F6
QNCX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -30,000
- Change %
- -18%
- Price
- $0.000000
- Shares after
- 133,294
- Date
- 17 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $2.23
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.63 to $94.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.66 to $95.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.68 to $96.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.89 to $97.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F6
The option vested as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.